Núria Nadal-Gratacós

Assistant Professor

University of Barcelona
Country flagSpain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Background and Purpose New psychoactive substances such as N ‐ethylpentylone (NEP) are continuously emerging in the illicit drug market, and knowledge of their effects and risks, which may vary between sexes, is scarce. Our present study compares some key effects of NEP in male and female mice. Experimental Approach Psychostimulant, rewarding and reinforcing effects were investigated by tracking locomotor activity, conditioned place preference (CPP) paradigm and through a self‐administration (SA) procedure, respectively, in CD1 mice. Moreover, the expression of early genes ( C ‐ fos , Arc , Csnk1e , Pdyn , Pp1r1b and Bdnf in addiction‐related brain areas) was assessed by qPCR. Finally, serum and brain levels of NEP were determined by UHPLC‐MS/MS. Key Results NEP‐treated males experimented locomotor sensitisation and showed higher and longer increases in locomotion as well as higher hyperthermia after repeated administration than females. Moreover, while preference score in the CPP was similar in both sexes, extinction occurred later, and reinstatement was more easily established for males. Female mice self‐administered more NEP than males at a higher dose. Differences in early gene expression ( Arc , Bdnf , Csnk1e and Ppp1r1b ) were found, but the serum and brain NEP levels did not differ between sexes. Conclusion and Implications Our results suggest that male mice are more sensitive to NEP psychostimulant and rewarding effects. These differences may be attributed to different early gene expression but not to pharmacokinetic factors. Moreover, males appear to be more vulnerable to the hyperthermic effects of NEP, while females might be more prone to NEP abuse.

Year:

2024

Year:

2024

Year:

2023

Collaborators (8)

Elena Escubedo

Professor of Pharmacology

University of Barcelona

SPAIN
View details

Miren Ettcheto

Profesor agregado

University of Barcelona

SPAIN
View details

Harald Sitte

Principal Investigator, Professor of Psychopharmacology

Medical University of Vienna

AUSTRIA
View details

Xavier Berzosa

Assisstant Professor

Universitat Ramon Llull

SPAIN
View details

Thomas Stockner

Assoc. Prof

Medical University of Vienna

AUSTRIA
View details

Marta Rodriguez-Arias

Professor

University of Valencia

SPAIN
View details

Marina Daiana Reguilón Romero

Profesora Ayudante Doctor

Universidad de Zaragoza

SPAIN
View details

Adriana Castro-Zavala

Instituto de Investigación Biomédica de Málaga

SPAIN
View details